人工器官市場規模、佔有率、成長分析（按器官類型、固定方法、最終用戶和地區）—2025 年至 2032 年產業預測

Artificial Organs Market Size, Share, and Growth Analysis, By Organ Type (Artificial kidney, Artificial liver), By Fixation (Implantable, Wearable), By End-User, By Region - Industry Forecast 2025-2032

出版日期: 2025年05月24日 | 出版商:

SkyQuest | 英文 182 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2023 年全球人工器官市場規模為 285 億美元，預計將從 2024 年的 307.5 億美元成長到 2032 年的 565 億美元，預測期間（2025-2032 年）的複合年成長率為 7.9%。

全球老化顯著提升了器官移植的重要性，尤其對於65歲以上的人而言，他們既是器官移植的接受者，也是器官移植的尋求者。隨著這一人群的成長，由於移植後併發症風險的增加，對假體的需求也隨之增加。患者數量的成長表明，隨著越來越多的患者需要接受移植手術，等待移植的名單可能會越來越長。 OPTN現代化計劃等創新旨在提高器官移植的系統效率和數據透明度。此外，3D生物列印等技術進步正獲得支持，用於製造排斥風險較低的人造器官。人工智慧與器官捐贈者相容性評估的整合，代表著復原和病人接受度決策流程邁出了變革性的一步。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業市場定位（2024年）
主要市場參與者所採取的策略
近期市場趨勢
公司市場佔有率分析（2024年）
主要企業簡介
- 公司詳情
- 產品系列分析
- 公司分部佔有率分析
- 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

Berlin Heart
Abbott
Boston Scientific
Cochlear
Edwards Lifesciences
Ekso Bionics
Jarvik Heart
Medtronic
SynCardia Systems
Zimmer Biomet
Wearable Artificial Organs, Inc
CARMAT
BiVACOR Inc.
TransMedics
Fresenius Medical Care

結論和建議

簡介目錄

Product Code: SQMIG35H2303

Global Artificial Organs Market size was valued at USD 28.5 billion in 2023 and is poised to grow from USD 30.75 billion in 2024 to USD 56.5 billion by 2032, growing at a CAGR of 7.9% during the forecast period (2025-2032).

The global aging population is significantly increasing the importance of organ transplantation, particularly among individuals over 65 who are both recipients and seekers of transplants. As this demographic grows, so does the demand for prosthetic devices, driven by their heightened risk of post-implantation complications. The growing numbers indicate a potential increase in transplant waiting lists as more patients require procedures. Innovations such as the OPTN Modernization Initiative aim to enhance system efficiency and data transparency in organ transplantation. Additionally, advancements like 3D bioprinting are gaining traction for creating artificial organs with a lower risk of rejection. The integration of artificial intelligence in assessing organ and donor compatibility represents a transformative step in decision-making processes for both recovery and patient acceptance.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Artificial Organs market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Artificial Organs Market Segments Analysis

Global Artificial Organs Market is segmented by Organ Type, Fixation, End-User and region. Based on Organ Type, the market is segmented into Artificial kidney, Artificial liver, Artificial lungs, Artificial pancreas, Artificial heart and Other organ types. Based on Fixation, the market is segmented into Implantable and Wearable. Based on End-User, the market is segmented into Hospitals, Academic and Research Institutes and Specialty Clinics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Artificial Organs Market

The Global Artificial Organs market is significantly driven by the rising prevalence of chronic illnesses like kidney failure, heart disease, and liver disease. As more patients experience organ dysfunction, the need for prosthetic organs, including dialysis machines, artificial hearts, and liver support systems, is rapidly increasing. This escalating demand is further accentuated by an aging population and deteriorating quality of life, contributing to an urgent need for life-saving medical interventions. Consequently, the surge in chronic disease cases is propelling the growth of the artificial organs market, highlighting the critical role these technologies play in improving patient outcomes and enhancing overall quality of care.

Restraints in the Global Artificial Organs Market

Although there have been significant advancements in technology, the exorbitant costs associated with prosthetics and related medical procedures continue to hinder the growth of the global artificial organs market. The extensive expenses incurred during the research, development, and manufacturing phases of these devices often render them unaffordable for a large segment of the global population, particularly in developing regions. Consequently, individuals with lower income levels or inadequate access to healthcare services face considerable barriers in obtaining prosthetic solutions. This financial constraint significantly restricts the reach and effectiveness of artificial organs, limiting their availability to those who need them the most.

Market Trends of the Global Artificial Organs Market

The Global Artificial Organs market is witnessing a significant trend driven by the integration of 3D printing technology in prosthetics. This innovation allows for the creation of customized, patient-specific organs that enhance accuracy, functionality, and biocompatibility, addressing individual healthcare needs more effectively. The ability to rapidly produce high-quality prosthetics at lower costs not only increases accessibility but also accelerates the manufacturing process, making 3D printing a pivotal segment within the market. As a result, stakeholders are increasingly investing in this technology, anticipating its role in reshaping healthcare solutions and improving the quality of life for patients worldwide.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Analysis
Patent Analysis

Global Artificial Organs Market Size by Organ Type & CAGR (2025-2032)

Market Overview
Artificial kidney
Artificial liver
Artificial lungs
Artificial pancreas
Artificial heart
Other organ types

Global Artificial Organs Market Size by Fixation & CAGR (2025-2032)

Market Overview
Implantable
Wearable

Global Artificial Organs Market Size by End-User & CAGR (2025-2032)

Market Overview
Hospitals
Academic and Research Institutes
Others

Global Artificial Organs Market Size & CAGR (2025-2032)

North America (Organ Type, Fixation, End-User)
- US
- Canada
Europe (Organ Type, Fixation, End-User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Organ Type, Fixation, End-User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Organ Type, Fixation, End-User)
- Brazil
- Rest of Latin America
Middle East & Africa (Organ Type, Fixation, End-User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

Berlin Heart
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boston Scientific
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cochlear
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Edwards Lifesciences
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ekso Bionics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Jarvik Heart
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SynCardia Systems
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Zimmer Biomet
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Wearable Artificial Organs, Inc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CARMAT
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BiVACOR Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
TransMedics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fresenius Medical Care
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments